Vaccines, Free Full-Text

Por um escritor misterioso
Last updated 22 dezembro 2024
Vaccines, Free Full-Text
To investigate early immune responses and explore the optimal vaccination periods, Nile tilapia at 1, 7, 14, 21, 28, 35, and 42 days after yolk sac collapse (DAYC) were immersed in formalin-killed Streptococcus agalactiae vaccine (FKV-SA). A specific IgM was first detected via ELISA in the 21 DAYC larvae (0.108 g) at 336 h after vaccination (hav), whereas in the 28–42 DAYC larvae (0.330–0.580 g), the specific IgM could be initially detected at 24 hav. qRT–PCR analysis of the TCRβ, CD4, MHCIIα, IgHM, IgHT, and IgHD genes in 21–42 DAYC larvae immunized with the FKV-SA immersion route for 24, 168, and 336 hav revealed that the levels of most immune-related genes were significantly higher in the vaccinated larvae at all DAYCs than in the control larvae (p < 0.05) at 336 hav. Immunohistochemistry demonstrated stronger IgM signals in the gills, head kidney, and intestine tissues at 21, 28, and 35 DAYC in all vaccinated larvae compared with the control. Interestingly, at all DAYCs, FKV-SA larvae exhibited significantly higher survival rates and an increased relative percent survival (RPS) than the control after challenge with viable S. agalactiae, particularly in larvae that were immunized with FKV-SA at 168 and 336 hav (p < 0.05).
Vaccines, Free Full-Text
Scent of a vaccine
Vaccines, Free Full-Text
Evaluation of the safety profile of COVID-19 vaccines: a rapid
Vaccines, Free Full-Text
SARS-CoV-2 vaccine protection and deaths among US veterans during
Vaccines, Free Full-Text
ASIIS-Web Main Page
Vaccines, Free Full-Text
A Brief History of Vaccination
Vaccines, Free Full-Text
COVID-19 Mobile Vaccination Clinic, City Calendar
Vaccines, Free Full-Text
Frontiers Predictors of COVID-19 Vaccine Acceptance, Intention
Vaccines, Free Full-Text
Find COVID‑19 vaccine locations near you
Vaccines, Free Full-Text
Influenza and COVID-19 Vaccination Coverage Among Health Care
Vaccines, Free Full-Text
Info for Parents

© 2014-2024 progresstn.com. All rights reserved.